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Summary
Hermansky-Pudlak syndrome (HPS) is a rare, autosomal
recessive disorder in which oculocutaneous albinism,
bleeding, and lysosomal ceroid storage result from de-
fects of multiple cytoplasmic organelles—melanosomes,
platelet-dense granules, and lysosomes. As reported else-
where, we mapped the humanHPS gene to chromosome
segment 10q23, positionally cloned the gene, and iden-
tified three pathologic mutations of the gene, in patients
from Puerto Rico, Japan, and Europe. Here, we describe
mutation analysis of 44 unrelated Puerto Rican and 24
unrelated non–Puerto Rican HPS patients. A 16-bp
frameshift duplication, the result of an apparent founder
effect, is nearly ubiquitous among Puerto Rican patients.
A frameshift at codon 322 may be the most frequent
HPS mutation in Europeans. We also describe six novel
HPS mutations: a 5′ splice-junction mutation of IVS5,
three frameshifts, a nonsense mutation, and a one-codon
in-frame deletion. These mutations define an apparent
frameshift hot spot at codons 321–322. Overall, how-
ever, we detected mutations in the HPS gene in only
about half of non–Puerto Rican patients, and we present
evidence that suggests locus heterogeneity for HPS.
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Introduction
Hermansky-Pudlak syndrome (HPS; MIM 203300) is
an autosomal recessive disorder characterized by tyros-
inase-positive oculocutaneous albinism, a tendency to
bleed, and a ceroid-lipofuscin lysosomal storage disease
(Hermansky and Pudlak 1959). At the cellular level, HPS
is associated with defects of multiple cytoplasmic or-
ganelles, including melanosomes, platelet-dense gran-
ules, and lysosomes (Hermansky and Pudlak 1959; Wit-
kop et al. 1990), and it likely results from a defect of a
protein required for the biogenesis, structure, or function
of these various membrane-bound organelles. Life-
threatening manifestations are frequent, and death typ-
ically results from restrictive lung disease (68%), hem-
orrhage (17%), or granulomatous colitis (15%), in pa-
tients aged 30–50 years (Witkop et al. 1990). There is
no specific therapy for HPS, and treatment is usually
limited to supportive care.
HPS is rare in most populations, but it is perhaps the
most common single-gene disorder in Puerto Rico,
where it occurs with an estimated frequency of ∼1/1,800
persons (Witkop et al. 1990). The disorder is also fre-
quent in a long-isolated village in the Swiss Alps (Lattion
et al. 1983; Schallreuter et al. 1993). These two patient
populations were instrumental to the mapping of the
HPS gene to 10q23 (Fukai et al. 1995; Wildenberg et
al. 1995) and to our eventual positional cloning of the
gene (Oh et al. 1996). The human HPS gene consists of
20 exons that span ∼30.5 kb (Bailin et al. 1997), and
it encodes a 700–amino acid polypeptide that contains
two apparent transmembrane domains but that has no
evident homology to any other known proteins (Oh et
al. 1996). Analysis of the mouse Hps gene (Feng et al.
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1997; Gardner et al. 1997) demonstrated that human
HPS is homologous to the murine pale-ear (ep) mutation,
which produces a phenotype that is not unlike that of
human HPS.
We described, elsewhere (Oh et al. 1996), three frame-
shifts in the HPS gene: a 16-bp duplication at codons
491–496, in Puerto Rican patients; a 1-bp duplication
at codon 441, in a Japanese patient; and a 1-bp dupli-
cation at codons 322–324, in the Swiss patients and in
an Irish HPS patient. Here, we describe mutation anal-
yses of 44 unrelated Puerto Rican HPS patients, 24 un-
related non–Puerto Rican HPS patients, and a patient
with isolated platelet-storage-pool deficiency. We show
that the common Puerto Rican codon 491–496 frame-
shift is nearly ubiquitous among HPS patients from this
Caribbean island. Among European HPS patients, the
codon 322–324 frameshift appears to be most frequent.
We also detected six novel mutations among the
non–Puerto Rican HPS patients; these mutations help to
define an apparent frameshift hot spot in the region of
codons 321–324. Though we describe one single-codon
deletion, we detected no missense mutations; this sug-
gests that most amino acid substitutions might not result
in the phenotype that is recognized as HPS.
Overall, we detected mutations in the HPS gene in
only about half of non–Puerto Rican HPS patients. In
addition, genetic mapping data exclude the HPS locus
in several of the patients who lack detectable mutations.
Together, these findings point toward locus heterogeneity
for HPS, particularly among non–Puerto Rican patients.
Material and Methods
Patient Samples and Mutation Analyses
Blood samples were collected from 44 unrelated
Puerto Rican HPS patients and selected relatives, ac-
cording to a protocol approved by the University of Wis-
consin Medical School Human Subjects Committee.
High–molecular-weight genomic DNA was prepared
from peripheral blood by use of the Puregene kit (Gentra
Systems). PCR analysis of the Puerto Rican 16-bp codon
491–496 duplication was carried out exactly as de-
scribed elsewhere (Oh et al. 1996).
For most of the 25 unrelated non–Puerto Rican pa-
tients (table 1), DNA was prepared from peripheral
blood samples as described above; although in some
cases DNA was prepared from cell or tissue samples by
use of the QIAamp Tissue Kit (Qiagen). DNA segments
that spanned exons of the HPS gene were amplified by
PCR, as described elsewhere (Bailin et al. 1997), and
were screened for mutations by means of nonradioactive
simultaneous SSCP/heteroduplex (HDX) analyses, per-
formed with mutation-detection electrophoresis gels (AT
Biochem), also as described elsewhere (Lee et al. 1995).
Samples from individuals who were homozygous and/
or heterozygous for all known polymorphisms (Bailin et
al. 1997) were included as controls for specific exons,
as relevant. PCR products that exhibited aberrant SSCP/
HDX patterns were reamplified in duplicate, purified by
use of the QIAEX II kit (Qiagen), and sequenced directly
by use of the Sequitherm Cycle Sequencing Kit (Epicentre
Technologies).
Genotype Analysis
High–molecular-weight DNA from relevant family
members was genotyped (see Oh et al. [1996] for a
detailed map) by means of four polymorphic microsat-
ellite markers that span ∼200 kb across the HPS gene
region of 10q23—D10S2437–D10S110/D10S184–
HPS–D10S2436–D10S2435 (D10S110 and D10S184
define the same polymorphism)—in accordance with
standard procedures (Dracopoli et al. 1994). One primer
of each pair was end-radiolabeled with 32P, and the PCR
products were analyzed by denaturing gel electropho-
resis and autoradiography. Alleles were assigned by vi-
sual inspection.
Results
Mutation Analysis of Puerto Rican HPS Patients
We described elsewhere a 16-bp frameshift duplica-
tion that involves codons 491–496, in exon 15 of the
HPS gene, in patients from Puerto Rico (Oh et al. 1996).
Results of direct PCR-based tests for this frameshift in
a total of 44 unrelated Puerto Rican HPS proposita (and
in a great many more affected relatives) indicated that
all were homozygous for this mutation (data not shown).
However, we did not detect this mutation in a patient
of mixed Puerto Rican/Dominican parentage (patient 24;
table1). Moreover, SSCP/HDX screening failed to detect
any apparent abnormality of the HPS gene in this pa-
tient. Thus, HPS is genetically nearly homogeneous in
Puerto Rico; it results from homozygosity for the HPS
codon 491–496 frameshift.
Mutation Analysis of Non–Puerto Rican HPS Patients
We found apparently pathologic mutations of theHPS
gene in 10 of the 24 unrelated non–Puerto Rican HPS
patients we studied. These data are summarized in table
1. Patients 1 and 2, described elsewhere (Oh et al. 1996),
represent the Swiss HPS group and an unrelated Irish-
German patient, respectively. All of these individuals
were homozygous for a 1-bp frameshift duplication, in
a poly(C) tract, at codons 322–324 (T322insC; fig. 1A).
However, these patients were divergent for intragenic
polymorphisms that flank this mutation on both sides;
this finding suggests that this frameshift probably arose
independently in these two groups (Oh et al. 1996). Pa-
tient 3 was also homozygous for the T322insC frame-
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Table 1
Results of Mutation Analysis of the HPS Gene in Non–Puerto Rican HPS Patients
Patient No. Mutationsa Ethnic Origin(s) Consanguinityb HPS Phenotype Comment(s)
1 T322insC/
T322insC
Swiss  Mild Oh et al. (1996)
2 T322insC/
T322insC
Irish/German  Mild Oh et al. (1996)
3 T322insC/
T322insC
French  Typical
4 T322insC/E666X Scottish  Mild
5 E397delC/
E397delC
American (USA)  Severe Coriell Cell Repository
(GM13958)
6 E397delC/
G321delG
Ukrainian  Typical
7 A441insA/
A441insA
Japanese  Typical Oh et al. (1996)
8 T322delC/
T322delC
Japanese  Severe
9 IVS5, 5GrA/
IVS5, 5GrA
Japanese  Typical
10 DI55/DI55 Afghan  Very mild
11 ND Dutch  Typical
12 ND Dutch  Typical Gerritsen et al. (1977)
13 ND Dutch  Typical
14 ND Dutch  Typical Atypical platelet-stor-
age-pool deficiency
15 ND Finnish  Mild
16 ND British  Typical Ellis et al. (1995)
17 ND Portuguese  Typical
18 ND Brazilian  Typical
19 ND Belgian  Typical
20 ND Japanese  Typical
21 ND American (USA)  Typical
22a ND Canadian  Typical
22b ND Canadian  Typical First cousin, once re-
moved, of 22a
22c ND Canadian  Typical First cousin of 22a;
first cousin, once re-
moved, of 22b
23 ND Canadian  Atypical HPS, frequent infec-
tions, and cyclic
neutropenia
24 ND Puerto Rican/
Dominican
 Typical
25 ND French  Platelet-storage-
pool deficiency
a ND  none detected.
b A plus sign () indicates presence, and a minus sign () indicates absence.
shift and was homozygous for the polymorphism hap-
lotype found in the patient of Irish-German origin.
Patient 4 was a compound heterozygote for the
T322insC frameshift, again associated with this same
polymorphism haplotype, and for a novel nonsense mu-
tation, E666X (fig. 1B).
Patient 5 was homozygous for a novel frameshift,
E397delC (fig. 1C), and patient 6 was a compound het-
erozygote for the E397delC frameshift and for another
novel frameshift, G321delG, a 1-bp deletion in a poly(G)
tract, at codons 320–321 (fig. 1D). Patient 7, described
elsewhere (Oh et al. 1996), was homozygous for a frame-
shift, A441insA (fig. 1E). Patient 8 was homozygous for
another novel frameshift, T322delC (fig. 1F), that in-
volves the same poly(C) tract involved in the T322insC
frameshift.
Patient 9 was homozygous for a novel mutation
within the 5′ splice consensus of IVS5, 5GrA (fig.
1G). We identified an apparent 5′ splice-consensus mu-
tation, IVS5 5GrA, in a Japanese HPS patient. The
5′ splice-junction consensus for primates is A58G78/
g100t100a57a71g84t47, where G is the most conserved nucle-
otide at position 5 (Shapiro and Senepathy 1987), and
substitutions at IVS nucleotide 5 can radically alter RNA
splicing patterns (Treisman et al. 1983; Cheng et al.
1984; Highsmith et al. 1990; Zielenski et al. 1995). We
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Figure 1 Mutations of the HPS gene in non–Puerto Rican HPS
patients. A, T322insC mutation, patients 1–4. B, E666X mutation,
patient 4. C, E397delC mutation, patients 5 and 6. D, G321delG
mutation, patient 6. E, A441insA mutation, patient 7. F, T322delC
mutation, patient 8. G, IVS5, 5GrA mutation, patient 9. H, DI55
mutation, patient 10.
Table 2
Genotyping of Inbred Non–Puerto Rican HPS Patients for Markers
That Immediately Surround the HPS Gene
PATIENT
NO.
MARKER(S)
D10S2437 D10S110/D10S184 D10S2436 D10S2435
15 1,3 2,2 1,1a 2,4
20 1,1 1,1 2,2 8,8
22a 1,3 1,2 1,2 1,2
23 1,3 1,2 1,1 1,9
NOTE.—The HPS gene is located between markers D10S110/
D10S184 and D10S2436 (D10S110 and D10S184 define the same
polymorphism).
a Uninformative marker.
failed to detect this mutation in 30 unrelated Asian in-
dividuals. Furthermore, patient 9 was also homozygous
for three nonpathologic polymorphisms of the HPS
gene—T99T ( in Asians), P491R ( inq  .23 q  .23
Asians), and R603Q ( in Asians)—that we haveq  .83
described elsewhere (Bailin et al. 1997). We sequenced
the exon 5 PCR product from five unrelated Asian in-
dividuals who were heterozygous for all three of these
polymorphisms, and none of them carried the 5′ splice-
consensus mutation (data not shown). Thus, this mu-
tation is not a common nonpathological polymorphism.
Patient 10 was homozygous for a deletion of three
bases (ATC) at a direct repeat at codons 55–56, which
results in an in-frame deletion, DI55 (fig. 1H). HPS pa-
tients 11–24 and patient 25 (who has isolated platelet-
storage-pool deficiency) had no detectable mutations of
the HPS gene.
Homozygosity Testing and Genetic Linkage Analyses
of Non–Puerto Rican HPS Patients
Our inability to detect HPS gene mutations in more
than half of the non–Puerto Rican HPS patients sug-
gested the possibility of locus heterogeneity for the
disorder. Four of the patients (15, 20, 22, and 23) in
whom we found no HPS mutations were inbred and,
thus, were suitable for homozygosity-by-descent tests,
performed by means of polymorphic markers that
span an ∼200-kb interval that embeds the HPS gene
in 10q23 (D10S2437–D10S110/D10S184–HPS–
D10S2436–D10S2435; see Oh et al. [1996] for a de-
tailed map). In addition, the extended families of pa-
tients 12 (non-inbred) and 22 (inbred) were suffi-
ciently large to allow tests for genetic linkage to these
markers.
As shown in table 2, patient 20, whose parents were
first cousins, was homozygous at all four of these
markers; nevertheless, DNA sequencing of almost the
entire HPS gene failed to detect any pathologic mu-
tations in this patient. Thus, patient 20 probably ei-
ther has an HPS gene mutation outside the regions
amplified by PCR or is homozygous for this region
on the basis of chance ( ).P  .0625
In contrast, patient 15, whose parents were distantly
related, was heterozygous at D10S2435 and D10S2437.
Patient 22a, whose parents were first cousins, was het-
erozygous for all four markers. Patient 23, whose par-
ents were second cousins, was heterozygous at
D10S2437, D10S110/D10S184, and D10S2435. Ge-
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Figure 2 A frameshift hot spot at codons 321–322 of the HPS
gene.
netic linkage analysis of the families of patients 12 and
22 excluded linkage to these four markers (minimum
LOD scores were  at and 4.282 atv  .00 v 
, respectively), and genotypes of the family of patient.00
23 were inconsistent with linkage to all four markers
(data not shown). Together, these results argue strongly
that HPS—in at least patients 12, 15, 22a, and 23—does
not result from mutations in the 10q23 HPS locus.
Discussion
W previously mapped the HPS gene to chromosome
10q23, by means of linkage disequilibrium analysis of
patients from two inbred groups, one from Puerto Rico
and the other from an isolated village in the Swiss Alps
(Fukai et al. 1995). We subsequently studied additional
patients from Puerto Rico to more finely localize and,
eventually, to positionally clone the HPS gene (Oh et al.
1996). We have now studied a total of 44 unrelated HPS
patients from Puerto Rico, and we have found that all
are homozygous for a 16-bp frameshift duplication,
which strongly indicates a founder effect in this island
population. Among non–Puerto Rican HPS patients, a
frameshift, T322insC, which occurs in a tract of cyto-
sines, appears to be the most common HPS gene mu-
tation. In fact, haplotype analysis performed with intra-
genic polymorphisms suggests that this mutation has
arisen at least twice in northern Europe (Oh et al. 1996).
The occurrence of two additional frameshifts, G321delG
and T322delC, in the immediate vicinity strongly indi-
cates that the codon 321–322 region constitutes a hot
spot for small duplications and deletions (fig. 2). This
is further supported by our observation of the T322delC
frameshift as a spontaneous inactivating mutation of the
human HPS cDNA in a heterologous yeast expression
system (data not shown).
It seems surprising that we have not yet identified
missense substitutions of the HPS gene in any HPS pa-
tients, although we previously described three nonpath-
ologic amino acid polymorphisms, G283W, P491R, and
R603Q (Bailin et al. 1997). Likewise, both of the two
extant ep mutations of mice result in frameshifts (Feng
et al. 1997). It may be that the phenotype that results
from amino acid substitutions in the HPS protein either
is clinically very mild or is so different from that of
classic HPS that this diagnosis is not generally made in
individuals who carry such mutations. In this regard, the
patient in whom we found a single-codon deletion of
I55/I56 may be instructive. This patient has a very mild
clinical phenotype that includes congenital nystagmus,
ocular albinism, and bruising associated with deficient
platelet-dense granules, but the patient has normal skin
and hair pigmentation. This patient is still an infant, and
it will thus be of interest to observe the phenotype as
the child grows and develops.
In more than half of the non–Puerto Rican HPS pa-
tients, and in the one patient with isolated platelet-stor-
age-pool deficiency, we found no apparent abnormalities
of the HPS gene. This low mutation-detection frequency
seemed surprising, and it suggested to us the possibility
of either a high frequency of occult mutations or locus
heterogeneity for HPS. Likewise, the absence of the co-
don 491–496 frameshift in an HPS patient of mixed
Puerto Rican/Dominican ancestry also suggested the ex-
istence of either allelic heterogeneity or locus heteroge-
neity, even in Puerto Rico. To distinguish between these
possibilities, we carried out homozygosity analysis of
four inbred HPS patients in whom we had detected no
mutations. If these patients were homozygous-by-de-
scent for occult HPS mutations, they should also be ho-
mozygous for the polymorphic markers we tested that
immediately flank the gene on both sides. However, three
of these patients were heterozygous for these markers;
this finding apparently excluded the HPS locus in these
cases. Furthermore, genetic linkage analysis of the ex-
tended family of one of these patients, as well as in
another, non-inbred family, showed no evidence for link-
age. Together, these results strongly support our hy-
pothesis of locus heterogeneity for HPS. A similar con-
clusion was recently reached by Hazelwood et al. (1997).
If there is a second HPS locus, what might it be? In
the mouse, there are at least 14 different loci that pro-
duce phenotypes similar to that of human HPS (Bennett
1993), some of which might thus constitute candidate
homologues. We (Feng et al. 1997) and others (Gardner
et al. 1997) have already shown that human HPS is
homologous to the mouse ep locus, located in the ho-
mologous region of murine chromosome 19. We pre-
viously considered another mouse mutant, ruby eye (ru),
as a possible HPS homologue, partly on the basis of its
phenotypic similarity to human HPS (Fukai et al. 1995)
and its location on chromosome 19. However, if human-
mouse synteny in this region has been conserved, our
genotype data would probably exclude the human ru
homologue as a likely second HPS locus, since the mouse
ep and ru loci are located only 1.3 cM apart (O’Brien
et al. 1994). Perhaps a better candidate for a second
human HPS locus would be the homologue to the mouse
light ear (le) locus. Light ear is located on mouse chro-
mosome 5, near Pdeb and Gus, although the precision
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of this localization is not high. The human Pdeb ho-
mologue (PDE6B) is located at 4p16.3, and the Gus
homologue (GUSB) is located at 7q22; these locations
can now be tested by homozygosity analysis of inbred
non–chromosome 10 HPS patients.
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